Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib effectively treats severe alopecia areata and is safe.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Suppressing ODC activity reduces tumor growth in hair follicles.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Baicalin nanocapsules greatly enhance its anticancer effects on breast cancer cells.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Nobiletin-loaded vesicles effectively treat skin cancer by restoring normal miRNA and antioxidant levels.

High S100A4 levels worsen glioblastoma by promoting blood vessel growth.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Bimatoprost solution 0.03% is effective for treating sparse eyelashes.

The document concluded that there were no effective ways to prevent hair loss from chemotherapy but treatments were being explored.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Hair regrowth was achieved using 5-Fluorouracil and Bleomycin for scalp atrophy caused by corticosteroids.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

A woman got melanoma on her scalp after anti-hair loss treatment with injections.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.